Nestin has also received attention as a cancer stem cell (CSC) marker in various tumor cells including CNS tumors, uterine and cervical cancer, prostate, bladder, head and neck, ovarian, testicular and pancreatic cancers as well as malignant rhabdoid tumors (34–41). Here, NES is linked to neoplasm.